A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient

SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma (ICC) has limited prognosis and therapies. The first-line gemcitabine-based therapy provided poor benefits in terms of survival due to the development of resistance. Gemcitabine-resistance mechanisms were studied on pancreatic cancer models or cell lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Peraldo-Neia, Caterina, Massa, Annamaria, Vita, Francesca, Basiricò, Marco, Raggi, Chiara, Bernabei, Paola, Ostano, Paola, Casorzo, Laura, Panero, Mara, Leone, Francesco, Cavalloni, Giuliana, Aglietta, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123022/
https://www.ncbi.nlm.nih.gov/pubmed/33922695
http://dx.doi.org/10.3390/cancers13092051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123022/
https://www.ncbi.nlm.nih.gov/pubmed/33922695
http://dx.doi.org/10.3390/cancers13092051

Ejemplares similares